These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2623428)

  • 21. IgG4 subclass antibody serology for onchocerciasis.
    Weil GJ; Ogunrinade AF; Chandrashekar R; Kale OO
    J Infect Dis; 1990 Mar; 161(3):549-54. PubMed ID: 2179425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guatemalan human onchocerciasis. I. Systematic analysis of patient populations, nodular antigens, and specific isotypic reactions.
    Tsang VC; Boyer AE; Pilcher JB; Eberhard ML; Reimer CB; Zea-Flores G; Zea-Flores R; Zhou W; Richards FO
    J Immunol; 1991 Jun; 146(11):3993-4000. PubMed ID: 2033267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum immunoglobulin E levels in onchocerciasis: the development of a radioallergosorbent test for Onchocerca volvulus infection.
    Titanji VP; Monebenimp F; Ngu JL
    Trop Med Parasitol; 1985 Mar; 36(1):12-6. PubMed ID: 4001765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda).
    Gallin MY; Jacobi AB; Büttner DW; Schönberger O; Marti T; Erttmann KD
    J Exp Med; 1995 Jul; 182(1):41-7. PubMed ID: 7790822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of an Onchocerca volvulus microfilarial antigen skin test in an epidemiological survey of onchocerciasis in Guatemala.
    Hashiguchi Y; Kawabata M; Zea G; Recinos MM; Flores O
    Trans R Soc Trop Med Hyg; 1979; 73(5):543-8. PubMed ID: 531907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of a heparan sulfate proteoglycan homologue OvPG-1 from Onchocerca volvulus.
    Amambua AN; Ghogomu SM; Tachu JB; Pelle R; Titanji VP
    East Afr Med J; 2005 Dec; 82(12):614-24. PubMed ID: 16619705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of an immunodominant Onchocerca volvulus antigen with patient sera and a monoclonal antibody.
    Lucius R; Schulz-Key H; Büttner DW; Kern A; Kaltmann B; Prod'hon J; Seeber F; Walter RD; Saxena KC; Diesfeld HJ
    J Exp Med; 1988 Apr; 167(4):1505-10. PubMed ID: 3356969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The profile of IgG and IgG subclasses of onchocerciasis patients.
    Dafa'alla TH; Ghalib HW; Abdelmageed A; Williams JF
    Clin Exp Immunol; 1992 May; 88(2):258-63. PubMed ID: 1572089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen detection in onchocerciasis: correlation with worm burden.
    Schlie-Guzmán MA; Rivas-Alcalá AR
    Trop Med Parasitol; 1989 Mar; 40(1):47-50. PubMed ID: 2740727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic diversity among Onchocerca volvulus in Nigeria, and immunological differences between onchocerciasis in the savanna and forest of Cameroon.
    Bryceson AD; van Veen KS; Oduloju AJ; Duke BO
    Clin Exp Immunol; 1976 Apr; 24(1):168-76. PubMed ID: 949872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cloning and characterization of recombinant parasite antigens for immunodiagnosis of onchocerciasis.
    Chandrashekar R; Masood K; Alvarez RM; Ogunrinade AF; Lujan R; Richards FO; Weil GJ
    J Clin Invest; 1991 Nov; 88(5):1460-6. PubMed ID: 1840605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique recognition of a low molecular weight Onchocerca volvulus antigen by IgG3 antibodies in chronic hyper-reactive oncho-dermatitis (Sowda).
    Cabrera Z; Buttner DW; Parkhouse RM
    Clin Exp Immunol; 1988 Nov; 74(2):223-9. PubMed ID: 3224441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.
    Ward DJ; Nutman TB; Zea-Flores G; Portocarrero C; Lujan A; Ottesen EA
    J Infect Dis; 1988 Mar; 157(3):536-43. PubMed ID: 3125261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of non-cross-reacting antigens of Onchocerca volvulus with lymphatic filariasis serum pools.
    Lobos E; Weiss N
    Parasitology; 1986 Oct; 93 ( Pt 2)():389-99. PubMed ID: 3785977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD).
    Ajonina-Ekoti I; Ndjonka D; Tanyi MK; Wilbertz M; Younis AE; Boursou D; Kurosinski MA; Eberle R; Lüersen K; Perbandt M; Breloer M; Brattig NW; Liebau E
    Acta Trop; 2012 Oct; 124(1):15-26. PubMed ID: 22677600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiological investigations of onchocerciasis in a hyperendemic area of West Africa.
    Karam M; Weiss N
    Am J Trop Med Hyg; 1985 Sep; 34(5):907-17. PubMed ID: 3898885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Onchocerca volvulus immunoglobulin subclass response in children from Sierra Leone.
    Gbakima AA; Ibrahim MS; Scott AL
    Scand J Immunol Suppl; 1992; 11():53-6. PubMed ID: 1514051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological studies on onchocerciasis in Sierra Leone. 1. Pretreatment baseline data.
    Luty AJ; Downham MD; Whitworth JA; Morgan D; McNicholas A; Taylor DW
    Trop Med Parasitol; 1990 Dec; 41(4):371-5. PubMed ID: 2075381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgE antibodies in human onchocerciasis. Application of a newly developed radioallergosorbent test (RAST).
    Weiss N; Speiser F; Hussain R
    Acta Trop; 1981 Sep; 38(3):353-62. PubMed ID: 6118043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.